We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Beam Therapeutics Inc | NASDAQ:BEAM | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.98 | 4.51% | 22.72 | 1,102,661 | 22:21:22 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 22.80 | 23.17 | 23.0565 | 22.00 | 22.08 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 377.71M | -132.53M | -1.6230 | -14.00 | 1.86B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 22:48:20 | 4 | 22.99 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 31/10/2023 | 10:59 | DJN | Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250.. |
Beam Therapeutics (BEAM) Share Charts1 Year Beam Therapeutics Chart |
|
1 Month Beam Therapeutics Chart |
Intraday Beam Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
